Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands.

COVID-19 Coronavirus Critical Care Intensive Care Mortality Outcome

Journal

Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873

Informations de publication

Date de publication:
13 Jan 2022
Historique:
received: 27 07 2021
accepted: 26 12 2021
entrez: 13 1 2022
pubmed: 14 1 2022
medline: 14 1 2022
Statut: epublish

Résumé

To assess trends in the quality of care for COVID-19 patients at the ICU over the course of time in the Netherlands. Data from the National Intensive Care Evaluation (NICE)-registry of all COVID-19 patients admitted to an ICU in the Netherlands were used. Patient characteristics and indicators of quality of care during the first two upsurges (N = 4215: October 5, 2020-January 31, 2021) and the final upsurge of the second wave, called the 'third wave' (N = 4602: February 1, 2021-June 30, 2021) were compared with those during the first wave (N = 2733, February-May 24, 2020). During the second and third wave, there were less patients treated with mechanical ventilation (58.1 and 58.2%) and vasoactive drugs (48.0 and 44.7%) compared to the first wave (79.1% and 67.2%, respectively). The occupancy rates as fraction of occupancy in 2019 (1.68 and 1.55 vs. 1.83), the numbers of ICU relocations (23.8 and 27.6 vs. 32.3%) and the mean length of stay at the ICU (HRs of ICU discharge = 1.26 and 1.42) were lower during the second and third wave. No difference in adjusted hospital mortality between the second wave and the first wave was found, whereas the mortality during the third wave was considerably lower (OR = 0.80, 95% CI [0.71-0.90]). These data show favorable shifts in the treatment of COVID-19 patients at the ICU over time. The adjusted mortality decreased in the third wave. The high ICU occupancy rate early in the pandemic does probably not explain the high mortality associated with COVID-19.

Sections du résumé

BACKGROUND BACKGROUND
To assess trends in the quality of care for COVID-19 patients at the ICU over the course of time in the Netherlands.
METHODS METHODS
Data from the National Intensive Care Evaluation (NICE)-registry of all COVID-19 patients admitted to an ICU in the Netherlands were used. Patient characteristics and indicators of quality of care during the first two upsurges (N = 4215: October 5, 2020-January 31, 2021) and the final upsurge of the second wave, called the 'third wave' (N = 4602: February 1, 2021-June 30, 2021) were compared with those during the first wave (N = 2733, February-May 24, 2020).
RESULTS RESULTS
During the second and third wave, there were less patients treated with mechanical ventilation (58.1 and 58.2%) and vasoactive drugs (48.0 and 44.7%) compared to the first wave (79.1% and 67.2%, respectively). The occupancy rates as fraction of occupancy in 2019 (1.68 and 1.55 vs. 1.83), the numbers of ICU relocations (23.8 and 27.6 vs. 32.3%) and the mean length of stay at the ICU (HRs of ICU discharge = 1.26 and 1.42) were lower during the second and third wave. No difference in adjusted hospital mortality between the second wave and the first wave was found, whereas the mortality during the third wave was considerably lower (OR = 0.80, 95% CI [0.71-0.90]).
CONCLUSIONS CONCLUSIONS
These data show favorable shifts in the treatment of COVID-19 patients at the ICU over time. The adjusted mortality decreased in the third wave. The high ICU occupancy rate early in the pandemic does probably not explain the high mortality associated with COVID-19.

Identifiants

pubmed: 35024981
doi: 10.1186/s13613-021-00978-3
pii: 10.1186/s13613-021-00978-3
pmc: PMC8755895
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5

Subventions

Organisme : ZonMw
ID : 10430 01 201 0011: IRIS
Pays : Netherlands

Investigateurs

Dirk P Verbiest (DP)
Leo F Te Velde (LF)
Erik M van Driel (EM)
Tom Rijpstra (T)
Paul W G Elbers (PWG)
Lyuba Georgieva (L)
Eva Verweij (E)
Remko M de Jong (RM)
Freya M van Iersel (FM)
Dick T J J Koning (DTJJ)
Els Rengers (E)
Nuray Kusadasi (N)
Michiel L Erkamp (ML)
Roy van den Berg (R)
Cretièn J M G Jacobs (CJMG)
Jelle L Epker (JL)
Annemiek A Rijkeboer (AA)
Martha T de Bruin (MT)
Peter Spronk (P)
Annelies Draisma (A)
Dirk Jan Versluis (DJ)
Lettie A E van den Berg (LAE)
Marissa Vrolijk-de Mos (MV)
Judith A Lens (JA)
D Jannet Mehagnoul-Schipper (DJ)
Diederik Gommers (D)
Johan G Lutisan (JG)
Martijn Hoeksema (M)
Ralph V Pruijsten (RV)
Hans Kieft (H)
Jan Rozendaal (J)
Fleur Nooteboom (F)
Dirk P Boer (DP)
Inge T A Janssen (ITA)
Laura van Gulik (L)
M Peter Koetsier (MP)
Vera M Silderhuis (VM)
Ronny M Schnabel (RM)
Ioana Drogt (I)
Wouter de Ruijter (W)
Rob J Bosman (RJ)
Tim Frenzel (T)
Louise C Urlings-Strop (LC)
Allard Dijkhuizen (A)
Ilanit Z Hené (IZ)
Arthur R de Meijer (AR)
Jessica W M Holtkamp (JWM)
Nynke Postma (N)
Alexander J G H Bindels (AJGH)
Ronald M J Wesselink (RMJ)
Eline R van Slobbe-Bijlsma (ER)
Peter H J van der Voort (PHJ)
Bob J W Eikemans (BJW)
Michel G W Barnas (MGW)
Barbara Festen-Spanjer (B)
Maarten van Lieshout (M)
Niels C Gritters (NC)
Martijn van Tellingen (M)
Gert B Brunnekreef (GB)
Joyce Vandeputte (J)
Tom P J Dormans (TPJ)
Marga E Hoogendoorn (ME)
Mart de Graaff (M)
David Moolenaar (D)
Auke C Reidinga (AC)
Jan Jaap Spijkstra (JJ)
Ruud de Waal (R)

Informations de copyright

© 2022. The Author(s).

Références

Richards-Belle A, Orzechowska I, Gould DW, Thomas K, Doidge JC, Mouncey PR, Christian MD, Shankar-Hari M, Harrison DA, Rowan KM, ICNARC COVID-19 Team. COVID-19 in critical care: epidemiology of the first pandemic wave across England, Wales and Northern Ireland. Intensive Care Med. 2020;46(11):2035–47. https://doi.org/10.1007/s00134-020-06267-0 .
doi: 10.1007/s00134-020-06267-0 pubmed: 33034689 pmcid: 7545019
Rhodes A, Ferdinande P, Flaatten H, Guidet B, Metnitz PG, Moreno RP. The variability of critical care bed numbers in Europe. Intensive Care Med. 2012;38(10):1647–53. https://doi.org/10.1007/s00134-012-2627-8 .
doi: 10.1007/s00134-012-2627-8 pubmed: 22777516
Albrecht R, Knapp J, Theiler L, Eder M, Pietsch U. Transport of COVID-19 and other highly contagious patients by helicopter and fixed-wing air ambulance: a narrative review and experience of the Swiss air rescue Rega. Scand J Trauma Resusc Emerg Med. 2020;28(1):40. https://doi.org/10.1186/s13049-020-00734-9 .
doi: 10.1186/s13049-020-00734-9 pubmed: 32410706 pmcid: 7222521
Janz DR, Khan YA, Mooney JL, Semler MW, Rice TW, Johnson JL, deBoisblanc BP, ICU MOVE Investigators and the Pragmatic Critical Care Research Group. Effect of interhospital ICU relocation on patient physiology and clinical outcomes. J Intensive Care Med. 2019;34(11–12):1010–6. https://doi.org/10.1177/0885066617726754 .
doi: 10.1177/0885066617726754 pubmed: 28820040
van de Klundert N, Holman R, Dongelmans DA, de Keizer NF. Data Resource Profile: the Dutch National Intensive Care Evaluation (NICE) registry of admissions to adult intensive care units. Int J Epidemiol. 2015;44(6):1850–1850h. https://doi.org/10.1093/ije/dyv291 .
doi: 10.1093/ije/dyv291 pubmed: 26613713
Prokop M, van Everdingen W, van Rees VT, Quarles van Ufford H, Stöger L, Beenen L, Geurts B, Gietema H, Krdzalic J, Schaefer-Prokop C, van Ginneken B, Brink M, COVID-19 Standardized Reporting Working Group of the Dutch Radiological Society. CO-RADS: a categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation. Radiology. 2020;296(2):E97–104. https://doi.org/10.1148/radiol.2020201473 .
doi: 10.1148/radiol.2020201473 pubmed: 32339082
Serafim RB, Póvoa P, Souza-Dantas V, Kalil AC, Salluh JIF. Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review. Clin Microbiol Infect. 2020;27(1):47–54. https://doi.org/10.1016/j.cmi.2020.10.017 .
doi: 10.1016/j.cmi.2020.10.017 pubmed: 33190794 pmcid: 7582054
Contou D, Fraissé M, Pajot O, Tirolien JA, Mentec H, Plantefève G. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave? Crit Care. 2021;25(1):3. https://doi.org/10.1186/s13054-020-03449-6 .
doi: 10.1186/s13054-020-03449-6 pubmed: 33397421 pmcid: 7780592
Kurtz P, Bastos LSL, Dantas LF, Zampieri FG, Soares M, Hamacher S, Salluh JIF, Bozza FA. Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months. Intensive Care Med. 2021;47(5):538–48. https://doi.org/10.1007/s00134-021-06388-0 .
doi: 10.1007/s00134-021-06388-0 pubmed: 33852032 pmcid: 8044656
Cals JWL, Derckx R, Blanker MH. Intensieve en palliatieve covid-19-zorg door huisarts [Intensive covid-19 care in general practice; nationwide registration study, initiated by General Practice Research Consortium Netherlands]. Ned Tijdschr Geneesk. 2021;164:D5616.
Harrison DA, Parry GJ, Carpenter JR, Short A, Rowan K. A new risk prediction model for critical care: the Intensive Care National Audit & Research Centre (ICNARC) model. Crit Care Med. 2007;35(4):1091–8. https://doi.org/10.1097/01.CCM.0000259468.24532.44 .
doi: 10.1097/01.CCM.0000259468.24532.44 pubmed: 17334248
Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, Klauber J, Janssens U, Marx G, Weber-Carstens S, Kluge S, Pfeifer M, Grabenhenrich L, Welte T, Busse R. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8(9):853–62. https://doi.org/10.1016/S2213-2600(20)30316-7 .
doi: 10.1016/S2213-2600(20)30316-7 pubmed: 32735842 pmcid: 7386882
Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, Tandjaoui-Lambiotte Y, Van Der Meersch G, Oziel J, Soulie M, Ghalayini M, Winchenne A, Zahar JR, Ahmed P, Gaudry S, Cohen Y. High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study. Ann Intensive Care. 2021;11(1):37. https://doi.org/10.1186/s13613-021-00825-5 .
doi: 10.1186/s13613-021-00825-5 pubmed: 33638752 pmcid: 7910764
Azoulay E, de Waele J, Ferrer R, Staudinger T, Borkowska M, Povoa P, Iliopoulou K, Artigas A, Schaller SJ, Shankar-Hari M, Pellegrini M, Darmon M, Kesecioglu J, Cecconi M. International variation in the management of severe COVID-19 patients. Crit Care. 2020;24(1):486. https://doi.org/10.1186/s13054-020-03194-w .
doi: 10.1186/s13054-020-03194-w pubmed: 32758266 pmcid: 7403819
Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126–36. https://doi.org/10.1056/NEJMra1208707 .
doi: 10.1056/NEJMra1208707 pubmed: 24283226
Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA. 2000;283(11):1451–9. https://doi.org/10.1001/jama.283.11.1451 .
doi: 10.1001/jama.283.11.1451 pubmed: 10732935
van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020;24(1):696. https://doi.org/10.1186/s13054-020-03400-9 .
doi: 10.1186/s13054-020-03400-9 pubmed: 33317589 pmcid: 7735177
Taccone FS, Goethem NV, Pauw Robby DE, van Beckhoven D, Meyfroidt G, Blot K. Organizational characteristics: effect on outcome of ICU COVID-19 patients in Belgium—authors’ reply. Lancet Reg Health Eur. 2021;3: 100070. https://doi.org/10.1016/j.lanepe.2021.100070 .
doi: 10.1016/j.lanepe.2021.100070 pubmed: 33870257 pmcid: 7980672
Dutch COVID & Thrombosis Coalition, Kaptein FHJ, Stals MAM, Grootenboers M, Braken SJE, Burggraaf JLI, van Bussel BCT, Cannegieter SC, Ten Cate H, Endeman H, Gommers DA, van Guldener C, de Jonge E, Juffermans NP, Kant KM, Kevenaar ME, Koster S, Kroft LJM, Kruip MJHA, Leentjens J, Marechal C, Soei YL, Tjepkema L, Visser C, Klok FA, Huisman MV. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res. 2020;199:143–8. https://doi.org/10.1016/j.thromres.2020.12.019 .
doi: 10.1016/j.thromres.2020.12.019
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3 .
doi: 10.1016/S0140-6736(20)30566-3 pubmed: 32171076 pmcid: 7270627

Auteurs

Dave A Dongelmans (DA)

National Intensive Care Evaluation (NICE) Foundation, PO Box 23640, 1100 EC, Amsterdam, The Netherlands.
Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Fabian Termorshuizen (F)

National Intensive Care Evaluation (NICE) Foundation, PO Box 23640, 1100 EC, Amsterdam, The Netherlands. F.Termorshuizen@amsterdamumc.nl.
Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. F.Termorshuizen@amsterdamumc.nl.

Sylvia Brinkman (S)

National Intensive Care Evaluation (NICE) Foundation, PO Box 23640, 1100 EC, Amsterdam, The Netherlands.
Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Ferishta Bakhshi-Raiez (F)

National Intensive Care Evaluation (NICE) Foundation, PO Box 23640, 1100 EC, Amsterdam, The Netherlands.
Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

M Sesmu Arbous (MS)

National Intensive Care Evaluation (NICE) Foundation, PO Box 23640, 1100 EC, Amsterdam, The Netherlands.
Department of Intensive Care Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.

Dylan W de Lange (DW)

National Intensive Care Evaluation (NICE) Foundation, PO Box 23640, 1100 EC, Amsterdam, The Netherlands.
Department of Intensive Care Medicine, University Medical Center, University of Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Bas C T van Bussel (BCT)

Department of Intensive Care Medicine, Maastricht University Medical Centre+, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
Maastricht University, Care and Public Health Research Institute (CAPHRI), Universiteitssingel 40, 6229 ER, Maastricht, The Netherlands.

Nicolette F de Keizer (NF)

National Intensive Care Evaluation (NICE) Foundation, PO Box 23640, 1100 EC, Amsterdam, The Netherlands.
Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Classifications MeSH